These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12403401)

  • 61. Burden of disease - prevalence and incidence of ESRD in selected European regions and populations.
    Covic A; Schiller A
    Clin Nephrol; 2010 Nov; 74 Suppl 1():S23-7. PubMed ID: 20979959
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Causes of chronic renal failure among Iranian hemodialysis patients.
    Malekmakan L; Haghpanah S; Pakfetrat M; Malekmakan A; Khajehdehi P
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):501-4. PubMed ID: 19414964
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative study of renal replacement therapy in Korean diabetic end-stage renal disease patients: a single center study.
    Choi SR; Lee SC; Kim BS; Yoon SY; Park HC; Kang SW; Choi KH; Kim YS; Ha SK; Park KI; Han DS; Lee HY
    Yonsei Med J; 2003 Jun; 44(3):454-62. PubMed ID: 12833583
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epidemiology of End-Stage Kidney Disease on Renal Replacement Therapy: 35 Years Analysis Study Nephrologists.
    Al-Za'abi RK; Tolmie EP; Rice AM; Mohsin N; Al-Busadi AS
    Saudi J Kidney Dis Transpl; 2021; 32(1):183-190. PubMed ID: 34145129
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Options in uraemia therapy for diabetics with end-stage renal disease.
    Polenaković MH
    Prilozi; 2004; 25(1-2):27-51. PubMed ID: 15735534
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Outcomes of rationing dialysis therapy in biopsy-proven end-stage renal disease in South Africa.
    Okpechi IG; Swanepoel CR; Rayner BL
    J Nephrol; 2012; 25(4):551-7. PubMed ID: 21956769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epidemiology of end-stage renal disease in an interregional perspective: Registries of Puglia and Basilicata, southern Italy.
    Vitullo F; Casino FG; Di Matteo A; Di Candia VD; Gaudiano V; Piras V; Alfonso L; Basile C; Procaccini DA; Gesualdo L;
    J Nephrol; 2003; 16(6):813-21. PubMed ID: 14736008
    [TBL] [Abstract][Full Text] [Related]  

  • 69. End-stage renal disease and renal replacement therapy in Kuwait--epidemiological profile over the past 4 1/2 years.
    El-Reshaid K; Johny KV; Sugathan TN; Hakim A; Georgous M; Nampoory MR
    Nephrol Dial Transplant; 1994; 9(5):532-8. PubMed ID: 8090333
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.
    van de Luijtgaarden MW; Jager KJ; Segelmark M; Pascual J; Collart F; Hemke AC; Remón C; Metcalfe W; Miguel A; Kramar R; Aasarød K; Abu Hanna A; Krediet RT; Schön S; Ravani P; Caskey FJ; Couchoud C; Palsson R; Wanner C; Finne P; Noordzij M
    Nephrol Dial Transplant; 2016 Jan; 31(1):120-8. PubMed ID: 26311215
    [TBL] [Abstract][Full Text] [Related]  

  • 71. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Course of chronic renal failure epidemiology and prediction of maintenance dialysis needs in France].
    Jungers P; Robino C; Choukroun G; Touam M; Fakhouri F; Grünfeld JP
    Nephrologie; 2001; 22(3):91-7. PubMed ID: 11436669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
    Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
    J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses.
    Castledine C; Casula A; Fogarty D
    Nephron Clin Pract; 2012; 120 Suppl 1():c29-54. PubMed ID: 22964573
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.
    Pippias M; Jager KJ; Kramer A; Leivestad T; Sánchez MB; Caskey FJ; Collart F; Couchoud C; Dekker FW; Finne P; Fouque D; Heaf JG; Hemmelder MH; Kramar R; De Meester J; Noordzij M; Palsson R; Pascual J; Zurriaga O; Wanner C; Stel VS
    Nephrol Dial Transplant; 2016 May; 31(5):831-41. PubMed ID: 26361801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. End-stage renal disease in the Asian-Pacific region.
    Lee G
    Semin Nephrol; 2003 Jan; 23(1):107-14. PubMed ID: 12563605
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Diabetic nephropathy as a cause of end-stage renal disease in Egypt: a six-year study.
    Afifi A; El Setouhy M; El Sharkawy M; Ali M; Ahmed H; El-Menshawy O; Masoud W
    East Mediterr Health J; 2004; 10(4-5):620-6. PubMed ID: 16335654
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changing trends in end-stage renal disease due to diabetes in the United kingdom.
    Hill CJ; Fogarty DG
    J Ren Care; 2012 Feb; 38 Suppl 1():12-22. PubMed ID: 22348360
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The 2006 ERA-EDTA Registry annual report: a précis.
    Stel VS; Kramer A; Zoccali C; Jager KJ
    J Nephrol; 2009; 22(1):1-12. PubMed ID: 19229813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.